← back to search

Johan Ahlgren

Lund University · SE
Area of research
Cancer Research · Oncology
Research interest
Research interests include Medicine, Breast cancer, Internal medicine, Tamoxifen, Oncology, and Mammography.
h-index
citations
1,369
works
13
NIH funding
primary concept
email

Recent publications

Comprehensive genome profiling for treatment decisions in patients with metastatic tumors: real-world evidence meta-analysis and registry data implementation
JNCI Journal of the National Cancer Institute 2025cited by 10position: middledoi
Effect of Smoking on Treatment Efficacy and Toxicity in Patients with Cancer: A Systematic Review and Meta-Analysis
Cancers 2022cited by 29position: middledoi
Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis – a population-based study
Acta Oncologica 2022cited by 26position: middledoi
Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study
Radiology 2021cited by 152position: middledoi
Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study
The Breast 2021cited by 39position: middledoi
Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women
Cancer 2020cited by 412position: middledoi
Sexual dysfunction and reproductive concerns in young women with breast cancer: Type, prevalence, and predictors of problems
Psycho-Oncology 2018cited by 172position: middledoi
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
Breast Cancer Research and Treatment 2018cited by 51position: middledoi
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
BMC Cancer 2017cited by 179position: middledoi
Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo – Meta-analyses on efficacy and adverse events based on randomized clinical trials
The Breast 2016cited by 62position: lastdoi
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study
Breast Cancer Research and Treatment 2016cited by 34position: middledoi
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study
Breast Cancer Research and Treatment 2012cited by 125position: middledoi
Impact of comorbidity on management and mortality in women diagnosed with breast cancer
Breast Cancer Research and Treatment 2012cited by 78position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mats Lambe · Karolinska Institutet4 papers (2012–2022)Hans Garmo · Uppsala University3 papers (2016–2021)Antonios Valachis · Örebro University3 papers (2021–2025)Lars Holmberg · Uppsala University3 papers (2016–2021)Leif Bergkvist · Uppsala University2 papers (2012–2017) · 2 papers (2012–2021)Tommy� Fornander · Karolinska University Hospital2 papers (2012–2012)Lena Wettergren · Uppsala University2 papers (2018–2022) · 2 papers (2022–2025)Claudia Lampic · Uppsala University2 papers (2018–2022)Annette Wigertz · Uppsala University Hospital2 papers (2012–2012)Lisa Rydén · Lund University2 papers (2016–2017)Irma Fredriksson · Karolinska University Hospital2 papers (2016–2021)Jan Adolfsson · Karolinska Institutet2 papers (2012–2012)Malin Sund · University of Helsinki2 papers (2016–2017)Sigurd Vitols · Karolinska University Hospital1 papers (2016–2016)Daniel J. Smıth · University of Leicester1 papers (2022–2022) · 1 papers (2025–2025)Fredrik Wärnberg · Sahlgrenska University Hospital1 papers (2012–2012)Chen-Yang Hsu · National Taiwan University1 papers (2021–2021)